for the treatment of rheumatic diseases, 2006 Updated consensus statement on biological agents

F Tatò, J Rieger, U Hoffmann, Refractory Takayasu's arteritis successfully treated with the human, monoclonal anti-tumor necrosis factor antibody adalimumab International Angiology. ,vol. 24, pp. 304- 307 ,(2005)

Noah Scheinfeld, Adalimumab (HUMIRA): a review. Journal of Drugs in Dermatology. ,vol. 2, pp. 375- 377 ,(2003)

MW Cravets, GR Burmester, JE Loveless, EC Keystone, P Dawes, F Magrini, R Jubb, RA Furie, J Isaacs, P Emery, Improved quality of life with rituximab plus methotrexate in patients with active rheumatoid arthritis who experienced inadequate response to one or more anti-TNF alpha therapies BSR Annual Meeting/BHPR Spring Meeting. ,(2006)

Shane A. Curran, Oliver M. FitzGerald, Patrick J. Costello, Jeanette M. Selby, David J. Kane, Barry Bresnihan, Robert Winchester, Nucleotide Sequencing of Psoriatic Arthritis Tissue before and during Methotrexate Administration Reveals a Complex Inflammatory T Cell Infiltrate with Very Few Clones Exhibiting Features That Suggest They Drive the Inflammatory Process by Recognizing Autoantigens Journal of Immunology. ,vol. 172, pp. 1935- 1944 ,(2004) , 10.4049/JIMMUNOL.172.3.1935

Ruy Carrasco, Judith A Smith, Daniel Lovell, Biologic agents for the treatment of juvenile rheumatoid arthritis: current status. Pediatric Drugs. ,vol. 6, pp. 137- 146 ,(2004) , 10.2165/00148581-200406030-00001

Michael R Liebling, Dinesh Khanna, James S Louie, Etanercept ameliorates sarcoidosis arthritis and skin disease. The Journal of Rheumatology. ,vol. 30, pp. 1864- 1867 ,(2003)

B Anne Eberhard, Beth S Gottlieb, Devyani Chowdhury, Jennifer E Weiss, Infliximab as a novel therapy for refractory Kawasaki disease. The Journal of Rheumatology. ,vol. 31, pp. 808- 810 ,(2004)

Pascal Claudepierre, Christophe Duvoux, Xavier Chevalier, Jean-Michel Pawlotsky, Dominique Challine, Owonayo Oniankitan, Arianne Mallat, Infliximab therapy for rheumatic diseases in patients with chronic hepatitis B or C. The Journal of Rheumatology. ,vol. 31, pp. 107- 109 ,(2004)

Charles A Birbara, Vibeke Strand, Daniel E Furst, Michael H Schiff, Roy M Fleischmann, Daniele Compagnone, Steven A Fischkoff, Elliot K Chartash, Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). The Journal of Rheumatology. ,vol. 30, pp. 2563- 2571 ,(2003)

Frederick Wolfe, James O'dell, Theodore Pincus, Evaluation and documentation of rheumatoid arthritis disease status in the clinic: which variables best predict change in therapy. The Journal of Rheumatology. ,vol. 28, pp. 1712- 1717 ,(2001)